Your browser doesn't support javascript.
loading
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial.
Shenderov, Eugene; De Marzo, Angelo M; Lotan, Tamara L; Wang, Hao; Chan, Sin; Lim, Su Jin; Ji, Hongkai; Allaf, Mohamad E; Chapman, Carolyn; Moore, Paul A; Chen, Francine; Sorg, Kristina; White, Andrew M; Church, Sarah E; Hudson, Briana; Fields, Paul A; Hu, Shaohui; Denmeade, Samuel R; Pienta, Kenneth J; Pavlovich, Christian P; Ross, Ashley E; Drake, Charles G; Pardoll, Drew M; Antonarakis, Emmanuel S.
Afiliación
  • Shenderov E; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA. Eugene.Shenderov@jhmi.edu.
  • De Marzo AM; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Baltimore, MD, USA. Eugene.Shenderov@jhmi.edu.
  • Lotan TL; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Wang H; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Chan S; Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Lim SJ; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Ji H; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Allaf ME; Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Chapman C; Department of Oncology Biostatistics and Bioinformatics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Moore PA; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Chen F; Department of Oncology Biostatistics and Bioinformatics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Sorg K; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • White AM; Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Church SE; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Hudson B; MacroGenics, Inc., Rockville, MD, USA.
  • Fields PA; MacroGenics, Inc., Rockville, MD, USA.
  • Hu S; NanoString Technologies Inc., Seattle, WA, USA.
  • Denmeade SR; NanoString Technologies Inc., Seattle, WA, USA.
  • Pienta KJ; NanoString Technologies Inc., Seattle, WA, USA.
  • Pavlovich CP; NanoString Technologies Inc., Seattle, WA, USA.
  • Ross AE; Adaptive Biotechnologies, Seattle, WA, USA.
  • Drake CG; CDI Labs, Baltimore, MD, USA.
  • Pardoll DM; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Antonarakis ES; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Nat Med ; 29(4): 888-897, 2023 04.
Article en En | MEDLINE | ID: mdl-37012549
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antineoplásicos Límite: Humans / Male Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antineoplásicos Límite: Humans / Male Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos